Guggenheim Says Bausch Health Companies (BHC) Sell-Off 'Overdone'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance
February 19, 2020 6:59 AM ESTLAVAL, Quebec, Feb. 19, 2020 /PRNewswire/ --Â
Fourth-Quarter 2019 Financial Results Revenues of $2.224 Billion GAAP Cash Generated from Operations of $234 Million GAAP Net Loss of $1.516 Billion Adjusted EBITDA (non-GAAP)1 of $898 Million Full-Year 2019 Financial Results Revenues of $8.601 Billion GAAP Cash Generated from Operations of $1.501 Billion GAAP Net Loss of $1.788 Billion Adjusted EBITDA (non-GAAP)1 of $3.571 Billion Delivered Total Company Reported Revenue Growth of 5% in the Fourth Quarter and 3% for... More